ArticleInfection and immunity2018
A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.
Open access · bronzeAbstract read
In one paragraph
Article in Infection and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 40 citations in OpenAlex.
- Bacterial lipid structural diversity mediates commensalism and pathogenesis.Nature reviews. Microbiology · 2026Review
- Antigenicity in mice of a recombinantVirulence · 2025Article
- Contribution of the different Neisseria gonorrhoeae lipooligosaccharide structural variants to functional responses elicited by GMMA outer membrane vesicles.NPJ vaccines · 2025Article
- Biologic drug development for treatment and prevention of sexually transmitted infections.Clinical microbiology reviews · 2025Review
- Interferon-epsilon, an estrogen-induced type I interferon, is uniquely exploited by Neisseria gonorrhoeae via effects on sialic acid metabolism.Cell host & microbe · 2025Article
- A novel GMMA-based gonococcal vaccine demonstrates functional immune responses in mice.NPJ vaccines · 2025Article
- Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context.The Journal of infectious diseases · 2024Review
- Article
- Article
- Article
- Article
- Article
- Bacterium of one thousand and one variants: genetic diversity ofMicrobial genomics · 2023Review
- Vertebrate and Invertebrate Animal and New In Vitro Models for StudyingPathogens (Basel, Switzerland) · 2023Review
- Comparison of lipooligosaccharides from human challenge strains ofFrontiers in microbiology · 2023Article
- Surface Anchoring of the Kingella kingae Galactan Is Dependent on the Lipopolysaccharide O-Antigen.mBio · 2022Article
- Selective Exoenzymatic Labeling of Lipooligosaccharides of Neisseria gonorrhoeae with α2,6-Sialoside Analogues.Chembiochem : a European journal of chemical biology · 2022Article
- How bacteria utilize sialic acid during interactions with the host: snip, snatch, dispatch, match and attach.Microbiology (Reading, England) · 2022Review
- Editorial: PathogenicFrontiers in cellular and infection microbiology · 2022Article
- Recent Progress Towards a Gonococcal Vaccine.Frontiers in cellular and infection microbiology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 4 institutions in 3 countries.
Sanjay RamDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA sanjay.ram@umassmed.edu.
Sunita GulatiDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Lisa A LewisDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Srinjoy ChakrabortiDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Bo ZhengDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Rosane B DeOliveiraDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
George W ReedPreventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Andrew D CoxHuman Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
Jianjun LiHuman Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
Frank St MichaelHuman Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
Jacek StupakHuman Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
Xiao-Hong SuDepartment of STD, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, People's Republic of China.
Sudeshna SahaDepartment of Medicine and Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California, USA.
Corinna S LandigDepartment of Medicine and Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California, USA.
Ajit VarkiDepartment of Medicine and Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California, USA.
Peter A RiceDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
University of Massachusetts Chan Medical School · USNational Research Council Canada · CAUniversity of California, San Diego · USChinese Academy of Medical Sciences & Peking Union Medical College · CN
Funding
BIOSYNTHESIS AND REGULATION OF SUBSTITUTED SIALIC ACIDSR01GM032373 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VARKI, AJIT P · 1985 to 2022
$6.9MNovel immunotherapeutics against multidrug-resistant Neisseria gonorrhoeaR01AI132296 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAM, SANJAY, RICE, PETER A. · 2017 to 2021
$5.5MImmune defenses against Neisseria gonorrhoeaeR01AI114790 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAM, SANJAY, RICE, PETER A. · 2015 to 2019
$3.1MVaccines and Immunotherapeutics against gonorrhea in the contex of Chlamydia coU01AI118161 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAM, SANJAY · 2014 to 2017
$2.0MLipooligosaccharide mimitope vaccines against Neisseria gonorrhoeaeR01AI114710 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GULATI, SUNITA, RICE, PETER A. · 2015 to 2018
$1.8MNIAID NIH HHS R01 AI114710NIAID NIH HHS R01 AI114790NIAID NIH HHS R01 AI132296NIAID NIH HHS U01 AI118161NIGMS NIH HHS R01 GM032373
Abstract
Sialylation of lacto-
Indexed as
AdultAnimalsAntibodies, BacterialAntibodies, MonoclonalChinaDisease Models, AnimalFemaleGonorrheaHealthy VolunteersHeptosesHumansLactoseLipopolysaccharidesMaleMass SpectrometryMiceAntibodies, BacterialAntibodies, MonoclonalHeptosesLactoselipid-linked oligosaccharidesLipopolysaccharidesN-Acetylneuraminic Acidcomplementfactor Hlipooligosaccharidemonoclonal antibodiesNeisseria gonorrhoeaeserum resistancesialic acidtherapeutic
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.